Cited by 916Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyTrauma, Hemostasis, Coagulopathy, Resuscitation

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Angiotensin II for the Treatment of Vasodilatory Shock

Open access

Khanna, Ashish, English, Shane W., Wang, Xueyuan S., Ham, Kealy, Tumlin, James, Szerlip, Harold, Busse, Laurence W., Altaweel, Laith, Albertson, Timothy E., Mackey, Caleb, McCurdy, Michael T., Boldt, David W., Chock, Stefan, Young, Paul J., Krell, Kenneth, Wunderink, Richard G., Ostermann, Marlies, Murugan, Raghavan, Gong, Michelle N., Panwar, Rakshit, Hästbacka, Johanna, Favory, Raphael, Venkatesh, Balasubramanian, Thompson, B. Taylor, Bellomo, Rinaldo, Jensen, Jeffrey, Kroll, Stew, Chawla, Lakhmir S., Tidmarsh, George F., Deane, Adam M.·2017·New England Journal of Medicine

DOI 10.1056/nejmoa1704154

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this condition. METHODS: We randomly assigned patients with vasodilatory shock who were receiving more than 0.2 μg of norepinephrine per kilogram of body weight per minute or the equivalent dose of another vasopressor to receive infusions of either angiotensin II or placebo. The primary end point was a response with respect to mean arterial pressure at hour 3 after the start of infusion, with response defined as an increase from baseline of at least 10 mm Hg or an increase to at least 75 mm Hg, without an increase in the dose of background vasopressors. RESULTS: A total of 344 patients were assigned to one of the two regimens; 321 received a study intervention (163 received angiotensin II, and 158 received placebo) and were included in the analysis. The primary end point was reached by more patients in the angiotensin II group (114 of 163 patients, 69.9%) than in the placebo group (37 of 158 patients, 23.4%) (odds ratio, 7.95; 95% confidence interval [CI], 4.76 to 13.3; P<0.001). At 48 hours, the mean improvement in the cardiovascular Sequential Organ Failure Assessment (SOFA) score (scores range from 0 to 4, with higher scores indicating more severe dysfunction) was greater in the angiotensin II group than in the placebo group (-1.75 vs. -1.28, P=0.01). Serious adverse events were reported in 60.7% of the patients in the angiotensin II group and in 67.1% in the placebo group. Death by day 28 occurred in 75 of 163 patients (46%) in the angiotensin II group and in 85 of 158 patients (54%) in the placebo group (hazard ratio, 0.78; 95% CI, 0.57 to 1.07; P=0.12). CONCLUSIONS: Angiotensin II effectively increased blood pressure in patients with vasodilatory shock that did not respond to high doses of conventional vasopressors. (Funded by La Jolla Pharmaceutical Company; ATHOS-3 ClinicalTrials.gov number, NCT02338843 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1704154

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

APACHE II
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine (see contributors to the project in the appendix)
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Epidemiology of severe sepsis
Mayr, F., Yende, S. P., & Angus, D. C. (2013) · Virulence · doi:10.4161/viru.27372 · Cited by 1,298
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*
López, A., Lorente, J. A., Steingrub, J. S., Bakker, J., McLuckie, A., Willatts, S. M., Brockway, M., Anzueto, A., Holzapfel, L., Breen, D. P., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000105581.01815.c6 · Cited by 917
Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock
Morelli, A., Ertmer, C., Westphal, M., Rehberg, S. W., Kampmeier, T., Ligges, S., Orecchioni, A., D’Egidio, A., D''Ippoliti, F., Raffone, C., et al. (2013) · JAMA · doi:10.1001/jama.2013.278477 · Cited by 739
History about the discovery of the renin-angiotensin system.
Basso, N., & Terragno, N. (2001) · HYPERTENSION · doi:10.1161/hy1201.101214 · Cited by 236
Survival After Shock Requiring High-Dose Vasopressor Therapy
Brown, S. M., Lanspa, M. J., Jones, J. P., Kuttler, K. G., Li, Y., Carlson, R., Miller, R. R., Hirshberg, E. L., Grissom, C. K., & Morris, A. H. (2013) · CHEST Journal · doi:10.1378/chest.12-1106 · Cited by 211

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 2

Chawla LS, 2017, Crit Care Resusc, 19, 43
Bassi E, 2013, Crit Care Res Pract, 2013, 654708

Sorted by citations

Items 801–900 of 916

Rescue Agents for Perioperative Vasoplegia
Wolfe, R. C. (2025) · Journal of PeriAnesthesia Nursing · doi:10.1016/j.jopan.2025.01.019
Selection of Vasopressors for Sepsis-Associated Acute Kidney Injury
朱, 汝. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541194
Angiotensin II - mechanism of action, current evidence and position paper of the interdisciplinary working group on its use in intensive care settings
Balík, M., Beneš, J., Černý, V., Kula, R., Matějovič, M., Říha, H., & Tencer, T. (2025) · Anesteziologie a intenzivní medicína · doi:10.36290/aim.2025.004
Sepsis et choc septique de l’adulte
de Roquetaillade, C., Bousta, A., Muchardt, J., & Chousterman, B. G. (2025) · EMC-Anesthésie réanimation/Encyclopédie médico-chirurgicale. Anesthésie, réanimation · doi:10.1016/s0246-0289(25)47121-7
Angiotensin II in Catecholamine-Refractory Shock: A Systematic Review and Exploratory Analysis of the Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Trial
Khallikane, S., Qamouss, Y., Elabdi, M., Bouzerda, A., Khatouri, A., Zyani, M., & Seddiki, R. (2025) · Cureus · doi:10.7759/cureus.86546
Inotropes, Vasopressors, and Antihypertensive Agents
Sierra, J. N. P. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197628638.003.0133
Sepsis and Septic Shock
Bauer, P. R. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197628638.003.0060
Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery
Lucchelli, M., Andreis, D. T., Gomarasca, M., & Mistraletti, G. (2025) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.31744
Hydrocortisone Dosing Frequency in Intensive Care Unit Patients With Septic Shock: A Comparison of 2 Regimens
Danos, A., Lear, A., Roach, E. M., & Quinn, N. J. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280251355619
Extracorporeal cytokine removal in refractory septic shock: A case of successful rescue with oXiris hemofiltration
Dilesh, P. K., Sasidharan, S., & Jha, V. K. (2025) · MRIMS Journal of Health Sciences · doi:10.4103/mjhs.mjhs_21_25
Comparison of Angiotensin II (Giapreza®) Use in Kidney Transplantation Between Black and Non-Black Patients
Tsai, M., Benken, J. J., Adisumarta, J., Anderson, E. M., Cheng, C., Ortiz, A., Benedetti, E., Nishioka, H., & Benken, S. T. (2025) · Biomedicines · doi:10.3390/biomedicines13081819
Angiotensina II en hipotensión resistente asociada a situaciones de choque
Vaca, E. R. (2025) · Panorama actual del medicamento · doi:10.63105/49.485.4
Assessment of Risk Factors for Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
Meyer, K. A., Brink, H. L., Brannan, S. C., Lundgren, S. W., Lyden, E. R., & Behlers, Q. B. (2025) · Cureus · doi:10.7759/cureus.90758
Vasodilatory Shock—From Initial Resuscitation to Rescue Therapies: Narrative Review and Considerations for Critical Care Transport
Bernardoni, B., Sayre, M., Roginski, M. A., Gottula, A. L., Esteves, A. M., Tschautscher, C. F., & Lauria, M. (2025) · Air Medical Journal · doi:10.1016/j.amj.2025.08.009
A review of safe and effective pharmacotherapies for Pediatric and neonatal septic shock
Chandrasekhar, M., & Nadel, S. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2571144
(Angiotensin II - mechanism of action, current evidence, and statement of the interdisciplinary working group on the use of angiotensin II in intensive care units)
Balík, M., Beneš, J., Černý, V., Kula, R., Matějovič, M., Říha, H., & Tencer, T. (2025) · Cor et Vasa · doi:10.33678/cor.2025.044
Professor Rinaldo Bellomo: Founder, architect, and choreographer of critical care nephrology
Bagshaw, S. M., & Kellum, J. A. (2025) · Critical Care and Resuscitation · doi:10.1016/j.ccrj.2025.100150
Letter to the editor: “Association of vasopressor use during renal replacement therapy and mortality”
Fu, Y., & Wang, Y. (2025) · Journal of Critical Care · doi:10.1016/j.jcrc.2025.155325
Sepsis y shock séptico en adultos
de Roquetaillade, C., Bousta, A., Muchardt, J., & Chousterman, B. G. (2025) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(25)51018-6
Sepsi e shock settico dell'adulto
de Roquetaillade, C., Bousta, A., Muchardt, J., & Chousterman, B. G. (2025) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(25)51071-x
Analysis of clinical experience with angiotensin II: A meta-analysis and 4 AI
de Val, I. I., Juarros, S. A., Gajino, M. M., Castillo, H. M., Casla, I. O., Álvarez, R. L., Martínez, L. S., & Burdio, J. J. A. (2025) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2025.502269
Feasibility of computer-aided aortic occlusion catheter in non-traumatic cardiac arrest
Rusnak, J., Thevathasan, T., Skurk, C., Zelniker, T. A., Frost, H., Eden, M., Speer, C., Frey, N., & Preusch, M. R. (2025) · Resuscitation · doi:10.1016/j.resuscitation.2025.110879
Inotropes and vasopressors (vasoactive drugs)
Deane, A. M., Khanna, A. K., & Myburgh, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11611-7.00026-8
Self-citation
Additional file 2 of Rapid implementation of an emergency on-site CKRT dialysate production system during the COVID-19 pandemic
Teixeira, J. P., Saa, L., Kaucher, K. A., Villanueva, R. D., Shieh, M., Baca, C. R., Harmon, B., Owen, Z. J., Majalca, I. M., Schmidt, D. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24012934
Additional file 1 of Angiotensin 1–7 in an experimental septic shock model
Garcia, B., Su, F., Manicone, F., Dewachter, L., Favory, R., Khaldi, A., Moiroux-Sahraoui, A., Moreau, A., Herpain, A., Vincent, J.-L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622369
Self-citation
Additional file 1 of The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock
Teixeira, J. P., Perez Ingles, D., Barton, J., Dean, J. T., García, P., Kunkel, S. J., Sarangarm, P., Weiss, N. K., Schaich, C. L., Busse, L. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25397473
Self-citation
Additional file 1 of Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial
Yanase, F., Spano, S., Maeda, A., Chaba, A., Naorungroj, T., Ow, C. P. C., Lankadeva, Y. R., May, C. N., Betrie, A. H., Lane, D. J. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26620210
Self-citation
Additional file 1 of Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury
Garcia, B., ter Schiphorst, B., Santos, K., Su, F., Dewachter, L., Vasques-Nóvoa, F., Rocha-Oliveira, E., Roncon‐Albuquerque, R., Uba, T. I., Hartmann, O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26731216
Self-citation
Additional file 1 of Incidence and management of metabolic acidosis with sodium bicarbonate in the ICU: An international observational study
Fujii, T., Udy, A. A., Nichol, A., Bellomo, R., Deane, A. M., El-Khawas, K., Thummaporn, N., Neto, A. S., Bergin, H., Short-Burchell, R. J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13698232
Self-citation
Additional file 2 of Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients
Dépret, F., Amzallag, J., Polina, A., Fayolle-Pivot, L., Coutrot, M., Chaussard, M., Santos, K., Hartmann, O., Jully, M., Fratani, A., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12177615
Additional file 4 of The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock
Teixeira, J. P., Perez Ingles, D., Barton, J., Dean, J. T., García, P., Kunkel, S. J., Sarangarm, P., Weiss, N. K., Schaich, C. L., Busse, L. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692291
Self-citation
Additional file 1 of Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock
Leisman, D. E., Handisides, D. R., Chawla, L. S., Albertson, T. E., Busse, L. W., Boldt, D. W., Deane, A. M., Gong, M. N., Ham, K. R., Khanna, A. K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26655175
Self-citation
Additional file 1 of Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients
Dépret, F., Amzallag, J., Polina, A., Fayolle-Pivot, L., Coutrot, M., Chaussard, M., Santos, K., Hartmann, O., Jully, M., Fratani, A., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12177603
Additional file 1 of Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial
Wieruszewski, P. M., Bellomo, R., Busse, L. W., Ham, K. R., Zarbock, A., Khanna, A. K., Deane, A. M., Ostermann, M., Wunderink, R. G., Boldt, D. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22774351
Self-citation
Additional file 2 of Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
Garcia, B., Su, F., Dewachter, L., Favory, R., Khaldi, A., Moiroux-Sahraoui, A., Annoni, F., Vasques-Nóvoa, F., Rocha-Oliveira, E., Roncon-Albuquerque, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21153767
Self-citation
Additional file 1 of Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
Garcia, B., Su, F., Dewachter, L., Favory, R., Khaldi, A., Moiroux-Sahraoui, A., Annoni, F., Vasques-Nóvoa, F., Rocha-Oliveira, E., Roncon-Albuquerque, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21153764
Self-citation
Additional file 3 of The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock
Teixeira, J. P., Perez Ingles, D., Barton, J., Dean, J. T., García, P., Kunkel, S. J., Sarangarm, P., Weiss, N. K., Schaich, C. L., Busse, L. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692288
Self-citation
Additional file 1 of Early administration of multiple vasopressors is associated with better survival in patients with sepsis: a propensity score-weighted study
Tong, X., Xue, X., Duan, C., & Liu, A. (2024) · Figshare · doi:10.6084/m9.figshare.26605957
Additional file 1 of The Sequential Organ Failure Assessment (SOFA) Score: has the time come for an update?
Moreno, R., Rhodes, A., Piquilloud, L., Glenn Hernández, P., Takala, J. A., Gershengorn, H. B., Tavares, M., Coopersmith, C. M., Myatra, S. N., Singer, M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603861
Additional file 1 of ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock
Leisman, D. E., Handisides, D. R., Busse, L. W., Chappell, M. C., Chawla, L. S., Filbin, M. R., Goldberg, M. B., Ham, K. R., Khanna, A. K., Ostermann, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26708750
Self-citation
Additional file 2 of The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock
Teixeira, J. P., Perez Ingles, D., Barton, J., Dean, J. T., García, P., Kunkel, S. J., Sarangarm, P., Weiss, N. K., Schaich, C. L., Busse, L. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25397686
Self-citation
Análisis de la experiencia clínica con angiotensina II: un metaanálisis y 4 inteligencias artificiales
de Val, I. I., Juarros, S. A., Gajino, M. M., Castillo, H. M., Casla, I. O., Álvarez, R. L., Martínez, L. S., & Burdio, J. J. A. (2025) · Medicina Intensiva · doi:10.1016/j.medin.2025.502269
Vasopressor therapy in septic shock
Jozwiak, M., Chew, M. S., & Khanna, A. K. (2025) · Intensive and Critical Care Nursing · doi:10.1016/j.iccn.2025.104307
Self-citation
Vasopressor Strategies for Septic Shock in Surgical and Trauma Critical Care: A Systematic Review and Network Meta-analysis
Valente, M. L. S., do Carmo, H. M. O., Fernandes, B. A. D. S. A., de Oliveira, S. G., Lima, L. B., Dalto, D. J., & de Magalhães, A. C. P. S. (2025) · Panamerican Journal of Trauma Critical Care & Emergency Surgery · doi:10.5005/jp-journals-10030-1503
Does a Research Paper Always Need a Hypothesis?
Charchaflieh, J. G., & Tung, A. (2026) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007932
Critical Care Management of Patients Awaiting Liver Transplantation
Rajakumar, A., & Paulin, S. M. (2026) · Springer eBooks · doi:10.1007/978-981-95-2624-6_17
Angiotensin II for the Treatment of Vasodilatory Shock during Percutaneous Hepatic Perfusion Cases: A Case Report
Andrew, C., Suriani, R. J., & Sparling, J. L. (2026) · A&A Practice · doi:10.1213/xaa.0000000000002141
Current evidence on septic shock in patients with cirrhosis
Serafim, L. P., & de Moraes, A. G. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001372
Intensivmedizinische Herausforderungen nach Operationen mit Herz-Lungen-Maschine
Renner, T., Krüger, B. D., Akbas, S., Gozdzik, M., & Karbach, M. (2026) · Intensivmedizin up2date · doi:10.1055/a-2576-7476
Dysregulation of renin-angiotensin-aldosterone axis in septic shock: Emerging roles of angiotensin-(1-5) and alamandine
Srinivasan, A., & Dhivya, P. (2026) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v15.i1.114670
A two-center comparison of the efficacy of methylene blue and hydroxocobalamin for the treatment of refractory shock
Leung, N., Dinh, C., Nguyen, L., Bakas, M. L., & Huang, W.-T. (2026) · Perfusion · doi:10.1177/02676591261432003
Vasoplegia After Cardiopulmonary Bypass: One Label, Multiple Phenotypes—A Minimal Reporting Standard for Interpretable Trials
Karczewska, K., & Szarpak, P. L. (2026) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2026.03.011
Intensivmedizinische Herausforderungen nach Operationen mit Herz-Lungen-Maschine
Renner, T., Krüger, B. D., Akbas, S., Gozdzik, M., & Karbach, M. (2026) · Journal Club AINS · doi:10.1055/a-2802-9883
Declaración de consenso sobre la definición, criterios diagnósticos y tratamiento de shock séptico refractario utilizando una metodología Delphi
Ojeda, D., Ferrer, R., Garnacho‐Montero, J., Maseda-Garrido, E., & Ochagavía, A. (2026) · Medicina Intensiva · doi:10.1016/j.medin.2026.502448
Dynamics of HIF-1α, TNF-α, IL-10, and Angiotensin II Biomarkers during the First 24 h in Patients with Refractory and Resolved Septic Shock: An Exploratory Study
Andriyanto, L., Yudianto, A., & Rehatta, N. M. (2026) · Bali Journal of Anesthesiology · doi:10.4103/bjoa.bjoa_303_25
Angiotensina II en el tratamiento del shock distributivo e identificación de perfiles clínicos con mayor beneficio terapéutico
Nieves‐Alonso, J., García-Álvarez, R., & Suárez-de-la-Rica, A. (2026) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2026.502116
International Utah Cardiac Recovery Symposium (U-CARS) 2025: Clinical Science Proceedings
Kyriakoulis, I., Nickel, I. C., Kanwar, M. K., Hanff, T. C., Stehlik, J., Selzman, C. H., & Drakos, S. G. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10621-7
Conséquences cardiovasculaires de l'agression rénale aiguë : interaction système rénine angiotensine aldostérone - galectine 3
Dépret, F. (2020) · theses.fr (ABES) · doi:10.70675/e8e1282ez76a8z4025z82cfz8a6bb0572cf6
An overview of reviews of Angiotensin II in distributive shock
Desfosses, M., & Røislien, J. (2026) · BMC Anesthesiology · doi:10.1186/s12871-026-03797-w
Insuffisance rénale aiguë en réanimation : facteurs de risque d'origine iatrogène et devenir à long terme
Jamme, M. (2022) · theses.fr (ABES) · doi:10.70675/8a25e63cz6f50z4a94z8cc6z006f4a65dd09
Current Practice in Post–Cardiac Surgery Shock: A European Association of Cardiothoracic Anesthesiology and Intensive Care Survey
Milne, B., Corredor, C., Naganathar, S., Vives, M., & Kunst, G. (2026) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2026.04.016
Targeting the renin-angiotensin system in sepsis-associated AKI: from pathophysiology to precision medicine
Dong, Y., Xia, L., & Shou, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1811635
Effect of Body Weight on Hemodynamic Response to Vasopressin in Patients With Septic Shock
Jorgensen, E. O., Custodio, M. M., He, R., & Urias, G. A. (2026) · Annals of Pharmacotherapy · doi:10.1177/10600280261436423
Toward endotype-guided renin-angiotensin-aldosterone system modulation in septic shock
Khanna, A. K., Annoni, F., & Picod, A. (2026) · Critical Care · doi:10.1186/s13054-026-06042-5
Self-citation
Consensus statement on the definition, diagnostic criteria, and treatment of refractory septic shock using a Delphi methodology
Andaluz‐Ojeda, D., Ferrer, R., Garnacho‐Montero, J., Maseda-Garrido, E., & Ochagavía, A. (2026) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2026.502448
Angiotensin II in the treatment of distributive shock and identification of clinical profiles with greater therapeutic benefit
Nieves‐Alonso, J., García-Alvarez, R., & Suárez-de-la-Rica, A. (2026) · Revista Española de Anestesiología y Reanimación (English Edition) · doi:10.1016/j.redare.2026.502116
Characterizing immune involvement in degenerative cervical myelopathy: a systematic review
Chabot, P. J., Winans, N. J., Fuller, J. S., Dadario, N. B., CreveCoeur, T. S., Rolfe, N. W., Howell, H. J., Sampath, S. G., Chou, D., & Chan, A. K.-H. (2026) · Journal of Neurosurgery Spine · doi:10.3171/2025.12.spine251122
Post–Heart Transplantation Intensive Care Unit Recovery
Friedman, A. L., Mery, M. W., Jelly, C. A., & Alvis, B. D. (2026) · Cardiology Clinics · doi:10.1016/j.ccl.2026.04.004
Refractory Shock in the Post–Cardiac Arrest Patient
Walker, A. C., & Johnson, N. J. (2026) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2026.04.003
Vasoplegic Shock beyond Traditional Concepts: A Narrative Review
Choudhuri, A. H. (2026) · Journal of Acute Care · doi:10.5005/jp-journals-10089-0224
Progress in Protective Hemodynamics Research
赵, 凯. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1652175
Effect of restrictive fluid balance in critically ill patients with acute kidney injury: a target trial emulation
White, K. C., Neto, A. S., Laupland, K. B., Gatton, M. L., Ramanan, M., Chaba, A., Whebell, S. F., Tabah, A., Shekar, K., McCullough, J., et al. (2026) · Critical Care · doi:10.1186/s13054-026-06094-7
Self-citation
Optimizing Timing and Dose of Starting Norepinephrine and Vasopressin in Septic Shock
Hiroto, G., Nishikimi, M., & Shime, N. (2026) · Life · doi:10.3390/life16060913
Role of Angiotensin II as a Vasoactive Agent to Treat Distributive Shock With a Focus on Preliminary Data in Pediatric‐Aged Patients
Ito, S., Spellman, K., Khan, S., & Tobias, J. D. (2026) · Pediatric Anesthesia · doi:10.1002/pan.70237
Inotropic and vasopressor therapy in the intensive care unit: Physiopathology and evidence-based insights
Fage, N., Bouizegarene, M., Radermacher, P., & Asfar, P. (2026) · Hemodynamics · doi:10.1097/hd9.0000000000000027
Early Management of Sepsis
Munroe, E. S., Peltan, I. D., & Prescott, H. C. (2026) · Critical Care Clinics · doi:10.1016/j.ccc.2026.05.002
Perioperative management of liver transplant
Ramanujan, K. S., Grate, J. C., Friedman, A. L., Cacioppo, B. J., Fiza, B., & Anderson, A. L. (2026) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2026.06.003
Management of Shock After Cardiac Surgery
Deschamps, J., Yao, R. J. R., Kumar, N., Zakaria, L., Donaldson, C. M., & Ghadimi, K. (2026) · Cardiology Clinics · doi:10.1016/j.ccl.2026.05.008
Recent perioperative challenges in anesthesia during expansion of heart transplantation
Wang, A., Hussain, N., Mudhar, A., Robbins, J., Friessen, J., Hicks, A., Satyapriya, S. V., Whitson, B., Bhandary, S. P., Khorsandi, M., et al. (2026) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-026-04365-6
Anesthetic management and obstetric outcome for open fetal myelomeningocele repair at a Japanese center: a retrospective cohort study
Nagata, S., Matsumoto, Y., Iura, A., & Yoshida, T. (2026) · BMC Anesthesiology · doi:10.1186/s12871-026-04048-8
Hemodynamic Impact of Vasopressor Therapy in Critically Ill Patients with Septic Shock in the Intensive Care Unit
RAMIREZ, F., & Rodriguez, J. D. A. (2026) · IECCMEXICO · doi:10.64784/224
Update in Liver Transplant Anesthesia
Rashid, J., Arango, D., & Lindberg, S. A. (2026) · Advances in Anesthesia · doi:10.1016/j.aan.2026.05.003
Dynamic changes in vasoactive-inotropic score and their prognostic value in severe sepsis and septic shock patients undergoing polymyxin B hemoperfusion: a real-world Asian ICU cohort study
Chang, W.-H., Wu, W.-J., Shen, H.-F., & Hu, T.-Y. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13907-1
Update on sepsis treatment
Chiscano‐Camón, L., Ruiz‐Rodríguez, J. C., Ruiz‐Sanmartín, A., Nicolás-Morales, P., Hernández-González, M., & Ferrer, R. (2026) · Journal of Intensive Care · doi:10.1186/s40560-026-00898-z
A multi-modal temporal fusion transformer for comprehensive decision support across the emergency care trajectory
Choi, D. H., Hong, K. J., Ryoo, H. W., Kim, J. H., Ro, Y. S., Kim, M. W., Lee, S. M., Shin, S. D., Song, K. J., Park, J. H., et al. (2026) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2026.105082
Sepsis and Septic Shock
Carpenter, S. L., & Coopersmith, C. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-22660-0_26
Hemodynamic Resuscitation and De-resuscitation
Rowe, M., & Ferrada, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-22660-0_7
Proteomic, transcriptomic, and metabolic mediators of postcardiopulmonary bypass vasoplegia syndrome
Galloway, A. C., Magro, C. A., Goparaju, C. M. V., Phillips, K., Tokoro, K., Zhou, H., Smith, D., Grossi, E. A., Zias, E. A., Mosca, R., et al. (2026) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2026.06.026 · Cited by 1
Conformational Basis of Functionally Selective Allosteric Modulation of the Angiotensin II type 1 Receptor by Small MoleculesPreprint
Liu, S., Xiao, P., Elgeti, M., Fine, E. J., Lucero, E., Vestergaard, M., Wang, J., Jyothidasan, A., Li, A., Qu, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.15.736838
Vasopressor Dosing Trajectories in Septic Shock According to Initial Antimicrobial Susceptibility and Infection Source Concordance: A Retrospective Observational Study
Yamaya, Y., Kuwana, T., Kinoshita, K., Takahashi, K., Nakabayashi, H., & Imai, T. (2026) · Medical Sciences · doi:10.3390/medsci14030394
Septic shock
Twichell, E., Sattler, L. A., & Reynolds, D. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001409
Association of Intraoperative Narrow Pulse Pressure during Normotension with Postoperative Acute Kidney Injury: A Retrospective Cohort Analysis
Yao, S., Liu, Q., Zeng, R., & Tang, C. (2026) · Anesthesiology · doi:10.1097/aln.0000000000006275
Sepsis-Induced Cardiomyopathy and Acute Respiratory Distress Syndrome
Bikram, O., Gabriel, E., & Yuri, M. (2026) · Cardiovascular Science · doi:10.70322/cvs.2026.10011
The Sepsis Trial Landscape: A Domain-Specific Systematic Review and Meta-analysis of Adult Sepsis Randomized Controlled TrialsPreprint
Premer, C., Starahs, M., Hare, J. M., & Merchant, R. C. (2026) · Research Square · doi:10.21203/rs.3.rs-10450697/v1
Rationale and design of a pilot randomized control trial of permissive hypotension after cardiac surgery: The PHACS trial
Miranda, D. W., Makarem, A., Liquori, C., Galvis, A., Bagchi, A., Nikolić, I., Aguirre, A. D., Bloom, J. P., Rabi, S. A., D’Alessandro, D. A., et al. (2026) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2026.100852
Hour-1 Sepsis Bundle: Updated Evidence
PASCALE, G. D., Cutuli, S. L., Carelli, S., Cisterna, I., Vecchio, P. D., Franchini, E. O., Grilli, F. L., Lombardi, G., Palladini, A., Tagliamonte, A., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15156049
Vasoplegia in Cardiac Surgery and Mechanical Circulatory Support: From Cardiopulmonary Bypass to Advanced Circulatory Support Devices
Torre, D. E., & Pirri, C. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13080378
Fulminant Pneumococcal Sepsis-induced Cardiomyopathy Managed with Venoarterial Extracorporeal Membrane Oxygenation: A Case Report
Jaros, K., Butrym, M., Rutkowska, K., & Trejnowska, E. (2026) · Bali Journal of Anesthesiology · doi:10.4103/bjoa.bjoa_110_26
Cardiovascular adrenoceptors physiology in patients with shock
Jozwiak, M., Singer, M., & Annane, D. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08589-x
Vasoactive Agent Selection Strategies in the Management of Cardiogenic Shock
Bohula, E. A., & Morrow, D. A. (2026) · Circulation · doi:10.1161/circulationaha.126.079463

Authors: Khanna, A., English, S. W., Wang, X. S., Ham, K., Tumlin, J., Szerlip, H., Busse, L. W., Altaweel, L., Albertson, T. E., Mackey, C., McCurdy, M. T., Boldt, D. W., Chock, S., Young, P. J., Krell, K., Wunderink, R. G., Ostermann, M., Murugan, R., Gong, M. N., Panwar, R., Hästbacka, J., Favory, R., Venkatesh, B., Thompson, B. T., Bellomo, R., Jensen, J., Kroll, S., Chawla, L. S., Tidmarsh, G. F., & Deane, A. M.
Affiliations: Cleveland Clinic (US)
Regions Hospital (US)
Inova Health System (US)
Albert Einstein College of Medicine (US)
University of Maryland, Baltimore (US)
Northwestern University (US)
ORCID: Khanna, Ashish
English, Shane W.
Ham, Kealy
Szerlip, Harold
Busse, Laurence W.
Albertson, Timothy E.
McCurdy, Michael T.
Young, Paul J.
Wunderink, Richard G.
Ostermann, Marlies
Murugan, Raghavan
Gong, Michelle N.
Panwar, Rakshit
Hästbacka, Johanna
Venkatesh, Balasubramanian
Thompson, B. Taylor
Bellomo, Rinaldo
Chawla, Lakhmir S.
Deane, Adam M.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2017-08-03
Volume: 377
Issue: 5
Pages: 419-430
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1704154
OpenAlex: W2614578436
Cited by: 916
References: 24
Citations by year: 2026: 100 · 2025: 103 · 2024: 121 · 2023: 103 · 2022: 90 · 2021: 95 · 2020: 123 · 2019: 80 · 2018: 75 · 2017: 25
FWCI: 64.87
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
ePrints Soton (University of Southampton) (submittedVersion)
Figshare (submittedVersion)
Työväentutkimus Vuosikirja (submittedVersion)
Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
NOVA (University of Newcastle Australia) (submittedVersion)
Funders: Bristol-Myers Squibb
GlaxoSmithKline
La Jolla Pharmaceutical Company
Alexion Pharmaceuticals
Regeneron Pharmaceuticals
Genentech
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
Keywords: angiotensin II, vasodilatory shock, septic shock, vasopressors, norepinephrine, mean arterial pressure, SOFA score, mortality, blood pressure response, adverse events, sepsis treatment, vasopressor-refractory shock, fluid resuscitation, vasopressor dose reduction, organ dysfunction, 28-day mortality
MeSH terms: Aged, Angiotensin II, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hypotension, Male, Middle Aged, Shock, Vasoconstrictor Agents, Organ Dysfunction Scores

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Angiotensin II for the Treatment of Vasodilatory Shock

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks